Free Trial

Senseonics 8/8/2024 Earnings Report

Senseonics logo
$0.85 -0.03 (-3.10%)
As of 01/17/2025 04:00 PM Eastern

Senseonics EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.03
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Senseonics Revenue Results

Actual Revenue
$4.87 million
Expected Revenue
$4.86 million
Beat/Miss
Beat by +$10.00 thousand
YoY Revenue Growth
N/A

Senseonics Announcement Details

Quarter
Time
After Market Closes

Senseonics Earnings Headlines

Free Stock Ticker Inside: This Indicator Caught Nvidia’s Rallies
I’m not one to make super bold statements… But today, I’m making an exception. Because I’m 100% convinced this is the best indicator I’ve used for trading Nvidia… Don’t believe me? Just take a look at the last two rallies: This powerful indicator caught both moves almost perfectly.
See More Senseonics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Senseonics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senseonics and other key companies, straight to your email.

About Senseonics

Senseonics (NYSE:SENS), a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

View Senseonics Profile

More Earnings Resources from MarketBeat